esophageal cancer (redirected from Cancer of the oesophagus)

Esophageal Cancer 

Definition

Esophageal cancer is a malignancy that develops in tissues of the hollow, muscular canal (esophagus) along which food and liquid travel from the throat to the stomach.

Description

Esophageal cancer usually originates in the inner layers of the lining of the esophagus and grows outward. In time, the tumor can obstruct the passage of food and liquid, making swallowing painful and difficult. Since most patients are not diagnosed until the late stages of the disease, esophageal cancer is associated with poor quality of life and low survival rates.

Squamous cell carcinoma is the most common type of esophageal cancer, accounting for 95% of all esophageal cancers worldwide. The esophagus is normally lined with thin, flat squamous cells that resemble tiny roof shingles. Squamous cell carcinoma can develop at any point along the esophagus but is most common in the middle portion.

Adenocarcinoma has surpassed squamous cell carcinoma as the most common type of esophageal cancer in the United States. Adenocarcinoma originates in glandular tissue not normally present in the lining of the esophagus. Before adenocarcinoma can develop, glandular cells must replace a section of squamous cells. This occurs in Barrett's esophagus, a pre-cancerous condition in which chronic acid reflux from the stomach stimulates a transformation in cell type in the lower portion of the esophagus.

A very small fraction of esophageal cancers are melanomas, sarcomas, or lymphomas.

There is great variability in the incidence of esophageal cancer with regard to geography, ethnicity, and gender. The overall incidence is increasing. About 13,000 new cases of esophageal cancer are diagnosed in the United States each year. During the same 12-month period, 12,000 people die of this disease. It strikes between five and ten North Americans per 100,000. In some areas of China the cancer is endemic.

Squamous cell carcinoma usually occurs in the sixth or seventh decade of life, with a greater incidence in African-Americans than in others. Adenocarcinoma develops earlier and is much more common in white patients. In general, esophageal cancer occurs more frequently in men than in women.

Causes and symptoms

The exact cause of esophageal cancer is unknown, although many investigators believe that chronic irritation of the esophagus is a major culprit. Most of the identified risk factors represent a form of chronic irritation. However, the wide variance in the distribution of esophageal cancer among different demographic groups raises the possibility that genetic factors also play a role.

Several risk factors are associated with esophageal cancer.

• Tobacco and alcohol consumption are the major risk factors, especially for squamous cell carcinoma. Smoking and alcohol abuse each increase the risk of squamous cell carcinoma by five-fold. The effects of the two are synergistic, in that the combination of smoking and alchohol increases the risk by 25- to 100- fold. It is estimated that drinking about 13 ounces of alcohol every day for an extended period of time raises the risk of developing esophageal cancer by 18%. That likelihood increases to 44% in individuals who also smoke one or two packs of cigarettes a day. Smokeless tobacco also increases the risk for esophageal cancer.
• Gastroesophageal reflux is a condition in which acid from the stomach refluxes backwards into the lower portion of the esophagus, sometimes causing symptoms of heartburn. In some cases of gastroesophageal reflux, the chronic exposure to acid causes the inner lining of the lower esophagus to change from squamous cells to glandular cells. This is called Barrett's esophagus. Patients with Barrett's esophagus are roughly 30 to 40 times more likely than the general population to develop adenocarcinoma of the esophagus.
• A diet low in fruits, vegetables, zinc, riboflavin, and other vitamins can increase risk of developing to esophageal cancer.
• Caustic injury to the esophagus inflicted by swallowing lye or other substances that damage esophageal cells can lead to the development of squamous cell esophageal cancer in later life.
• Achalasia is a condition in which the lower esophageal sphincter (muscle) cannot relax enough to let food pass into the stomach. Squamous cell esophageal cancer develops in about 6% of patients with achalasia.
• Tylosis is a rare inherited disease characterized by excess skin on the palms and soles. Affected patients have a much higher probability of developing esophageal cancer than the general population. They should have regular screenings to detect the disease in its early, most curable stages.
• Esophageal webs, which are protrusions of tissue into the esophagus, and diverticula, which are out-pouchings of the wall of the esophagus, are associated with a higher incidence of esophageal cancer.

Symptoms

Unfortunately, symptoms generally don't appear until the tumor has grown so large that the patient cannot be cured. Dysphagia (trouble swallowing or a sensation of having food stuck in the throat or chest) is the most common symptom. Swallowing problems may occur occasionally at first, and patients often react by eating more slowly and chewing their food more carefully and, as the tumor grows, switching to soft foods or a liquid diet. Without treatment, the tumor will eventually prevent even liquid from passing into the stomach. A sensation of burning or slight mid-chest pressure is a rare, often-disregarded symptom of esophageal cancer. Painful swallowing is usually a symptom of a large tumor obstructing the opening of the esophagus. It can lead to regurgitation of food, weight loss, physical wasting, and malnutrition. Anyone who has trouble swallowing, loses a significant amount of weight without dieting, or cannot eat solid food because it is too painful to swallow should see a doctor.

Diagnosis

A barium swallow is usually the first test performed on a patient whose symptoms suggest esophageal cancer. After the patient swallows a small amount of barium, a series of x rays can highlight any bumps or flat raised areas on the normally smooth surface of the esophageal wall. It can also detect large, irregular areas that narrow the esophagus in patients with advanced cancer, but it cannot provide information about disease that has spread beyond the esophagus. A double contrast study is a barium swallow with air blown into the esophagus to improve the way the barium coats the esophageal lining. Endoscopy is a diagnostic procedure in which a thin lighted tube (endoscope) is passed through the mouth, down the throat, and into the esophagus. Cells that appear abnormal are removed for biopsy. Once a diagnosis of esophageal cancer has been confirmed through biopsy, staging tests are performed to determine whether the disease has spread (metastasized) to tissues or organs near the original tumor or in other parts of the body. These tests may include computed tomography, endoscopic ultrasound, thoracoscopy, laparoscopy, and positron emission tomography.

Treatment

Treatment for esophageal cancer is determined by the stage of the disease and the patient's general health. The most important distinction to make is whether the cancer is curable. If the cancer is in the early stages, cure may be possible. If the cancer is advanced or if the patient will not tolerate major surgery, treatment is usually directed at palliation (relief of symptoms only) instead of cure.

Staging

Stage 0 is the earliest stage of the disease. Cancer cells are confined to the innermost lining of the esophagus. Stage I esophageal cancer has spread slightly deeper, but still has not extended to nearby tissues, lymph nodes, or other organs. In Stage IIA, cancer has invaded the thick, muscular layer of the esophagus that propels food into the stomach and may involve connective tissue covering the outside of the esophagus. In Stage IIB, cancer has spread to lymph nodes near the esophagus and may have invaded deeper layers of esophageal tissue. Stage III esophageal cancer has spread to tissues or lymph nodes near the esophagus or to the trachea (windpipe) or other organs near the esophagus. Stage IV cancer has spread to distant organs like the liver, bones, and brain. Recurrent esophageal cancer is disease that develops in the esophagus or another part of the body after initial treatment.

Surgery

The most common operations for the treatment of esophageal cancer are esophagectomy and esophagogastrectomy. Esophagectomy is the removal of the cancerous part of the esophagus and nearby lymph nodes. This procedure is performed only on patients with very early cancer that has not spread to the stomach. Esophagogastrectomy is the removal of the cancerous part of the esophagus, nearby lymph nodes, and the upper part of the stomach. The resected esophagus is replaced with the stomach or parts of intestine so the patient can swallow. These procedures can significantly relieve symptoms and improve the nutritional status of more than 80% of patients with dysphagia. Although surgery can cure some patients whose disease has not spread beyond the esophagus, but more than 75% of esophageal cancers have spread to other organs before being diagnosed. Less extensive surgical procedures can be used for palliation.

Chemotherapy

Oral or intravenous chemotherapy alone will not cure esophageal cancer, but pre-operative treatments can shrink tumors and increase the probability that cancer can be surgically eradicated. Palliative chemotherapy can relieve symptoms of advanced cancer but will not alter the outcome of the disease.

Radiation

External beam or internal radiation, delivered by machine or implanted near cancer cells inside the body, is only rarely used as the primary form of treatment. Post-operative radiation is sometimes used to kill cancer cells that couldn't be surgically removed. Palliative radiation is effective in relieving dysphagia in patients who cannot be cured. However, radiation is most useful when combined with chemotherapy as either the definitive treatment or preoperative treatment.

Palliation

In addition to surgery, chemotherapy, and radiation, other palliative measures can provide symptomatic relief. Dilatation of the narrowed portion of the esophagus with soft tubes can provide short-term relief of dysphagia. Placement of a flexible, self-expanding stent within the narrowed portion is also useful in allowing more food intake.

Follow-up treatments

Regular barium swallows and other imaging studies are necessary to detect recurrence or spread of disease or new tumor development.

Alternative treatment

Photodynamic therapy (PDT) involves intravenously injecting a drug that is absorbed by cancer cells and kills them after they are exposed to specific laser beams. PDT can be used for palliation, but it also cured some early esophageal cancers during preliminary studies. Researchers are comparing its benefits with those of more established therapies.

Endoscopic laser therapy involves delivering short, powerful laser treatments to the tumor through an endoscope. It can improve dysphagia, but multiple treatments are required, and the benefit is seldom long-lasting.

Prognosis

Since most patients are diagnosed when the cancer has spread to lymph nodes or other structures, the prognosis for esophageal cancer is poor. Generally, no more than half of all patients are candidates for curative treatment. Even if cure is attempted, the cancer can recur.

Prevention

There is no known way to prevent esophageal cancer.

Resources

Books

Heitmiller, Richard F., Arlene A. Forastiere, and Lawrence R. Kleinberg. "Esophagus." In Clinical Oncology, edited by Martin D. Abeloff, 2nd ed. New York: Churchill Livingstone, 2000.

Zwischenberger, Joseph B., Scott K. Alpard, and Mark B.Orringer. "Esophageal Cancer." In Sabiston Textbook of Surgery, edited by Courtney Townsend, Jr., 16th ed. Philadelphia: W. B. Saunders Company, 2001.

Organizations

American Cancer Society. 1599 Clifton Road NE, Atlanta, GA 30329. (800)ACS-2345. http://www.cancer.org.

National Coalition for Cancer Survivorship. 1010 Wayne Avenue, 5th Floor, Suite 300, Silver Spring, MD 20910. Telephone: 1-888-650-9127.

Key terms

Computed tomography — A radiology test by which images of cross-sectional planes of the body are obtained.

Endoscopic ultrasound — A radiology test utilizing high frequency sound waves, conducted via an endoscope.

Laparoscopy — Examination of the contents of the abdomen through a thin, lighted tube passed through a small incision.

Positron emission tomography — A radiology test by which images of cross-sectional planes of the body are obtained, utilizing the properties of the positron. The positron is a subatomic particle of equal mass to the electron, but of opposite charge.

Synergistic — The combined action of two or more processes is greater than the sum of each acting separately.

Thoracoscopy — Examination of the contents of the chest through a thin, lighted tube passed through a small incision.

---

esophageal cancer,

a rare malignant neoplastic disease of the esophagus that peaks at about 60 years of age, occurs three times more frequently in men than in women, and is found more often in Asia and Africa than in North America. Risk factors associated with the disease are heavy consumption of alcohol, tobacco smoking, betel-nut chewing, Plummer-Vinson syndrome, Barrett's esophagus, and achalasia. Aflatoxin in moldy grain and peanuts or a dietary deficiency, especially of molybdenum, may be involved. Esophageal cancer does not often cause any symptoms in the early stages but in later stages produces painful dysphagia, chest pain, anorexia, weight loss, regurgitation, cervical adenopathy, and, in some cases, persistent cough. Left vocal cord paralysis and hemoptysis indicate an advanced state of the disease. Esophageal cancer metastasizes rapidly and thus has a poor prognosis. The tumor may spread locally to invade the trachea, bronchi, pericardium, great blood vessels, and thoracic vertebrae or may metastasize to lymph nodes, the lungs, and the liver. Diagnostic measures include barium swallow, fiberoptic esophagoscopy, and biopsy and cytologic examination of the primary lesion and regional nodes. Most esophageal tumors are poorly differentiated squamous cell carcinomas; adenocarcinomas occur less frequently and are usually found in the lower third of the esophagus. Surgical treatment may require total or partial esophagectomy. Radiotherapy may eradicate early local tumors and may effectively palliate the symptoms of an advanced lesion. Chemotherapy may be used in palliation of advanced disease or as an adjuvant to surgery or radiation therapy. See also esophagectomy.

---

esophageal cancer

GI disease A malignancy of the esophagus, most commonly, SCC and adenoCA Epidemiology ♂:♀, 3:1; age 55-70; ↑ in China, Japan, Scotland, Russia, Scandinavia; ±12,000 new cases/yr US; blacks have a 4-fold greater risk than whites–rate 1/105 ♀, 4/105 ♂ Risk factors Alcohol, tobacco use, poor nutrition, Hx of achalasia, corrosive esophagitis, Barrett's esophagus, tylosis palmaris et plantaris Clinical Dysphagia, retrosternal discomfort and pain, pressure, burning, and a sensation of food being stuck, eventually, narrowing of esophagus becomes severe, with choking, vomiting, weight loss Types SCC, ≥ 70%; adenoCA in Barrett's esophagus–10-20% Diagnosis Barium swallow to ID lesions arising in the esophageal mucosa, upper GI endoscopy/esophagoscopy with Bx and cytology brushings Staging CT, MRI, ultrasound Treatment Cisplatin, 5-FU, RT–5000 cGy is better than RT alone–6400 cGy for local control of CA, metastasis, ↑ survival, but ↑ side effects Prognosis Median survival, 10 months; 5-yr survival, 20–36%

Esophageal cancer–stages

I  CA in esophageal mucosa; no spread to nearby tissues, lymph nodes, or organs

II  CA in all layers of esophagus and/or regional lymph nodes; no spread to other tissues

III  CA has spread to tissues or lymph nodes near the esophagus; no metastasis

IV  CA has metastasized